March 2018 - Page 20 of 48 - NetworkNewsWire

TuesdayMar 13, 2018 11:00 am

Genfit SA (GNFTF) Starts Presentation at 30th Annual ROTH Conference

Genfit (OTC: GNFTF) is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. The company’s therapeutic and diagnostic solutions address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver. Genfit provides diagnostic solutions in various therapeutic areas, such as metabolic diseases, liver diseases, non-alcoholic steato-hepatitis, cholestatic liver diseases, inflammation and autoimmune diseases, and inflammatory bowel diseases. For more information, visit the company’s website at www.genfit.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access…

TuesdayMar 13, 2018 11:00 am

Vertex Energy, Inc. (NASDAQ: VTNR) Starts Presentation at 30th Annual ROTH Conference

Vertex Energy (NASDAQ: VTNR) is a Houston, Texas-based specialty refiner of alternative feedstocks and a marketer of high-purity petroleum products. The company is one of the largest processors of used motor oil in the United States and has processing capacity of more than 115 million gallons per year. Vertex has implemented the most cost-effective strategy for building its feedstock supply by establishing a successful self-collection and aggregation system. The company has also built a reputation as a key supplier of Group II+ and Group III base oils to the lubricant manufacturing industry in North America. For more information, visit the…

TuesdayMar 13, 2018 11:00 am

Viking Therapeutics, Inc. (NASDAQ: VKTX) Starts Presentation at 30th Annual ROTH Conference

Viking Therapeutics (NASDAQ: VKTX) is a clinical-stage biopharmaceutical company engaged in developing novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s R&D activities leverage its expertise in metabolism to develop innovative therapeutics designed to improve patients' lives. The company has global rights to a portfolio of five therapeutic programs in clinical trials or preclinical studies that are based on small molecules licensed from Ligand Pharmaceuticals Incorporated. For more information, visit the company’s website at www.vikingtherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via…

TuesdayMar 13, 2018 11:00 am

Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) Starts Presentation at 30th Annual ROTH Conference

Ritter Pharmaceuticals (NASDAQ: RTTR) is engaged in the development of novel therapeutics that modulate the gut microbiome to treat gastrointestinal diseases. RP-G28, the company’s lead product, has the potential to become the very first FDA-approved lactose intolerance treatment, addressing a condition that affects millions of individuals throughout the world. This product has been studied in phase 2 trials and is currently in phase 3 clinical development. Ritter Pharmaceuticals is additionally exploring the functionality and discovering the therapeutic potential of gut microbiome changes on treating and/or preventing various conditions, including gastrointestinal diseases, immuno-oncology, metabolic and liver disease. For more information, visit…

TuesdayMar 13, 2018 11:00 am

Panhandle Oil and Gas, Inc. (NYSE: PHX) Starts Presentation at 30th Annual ROTH Conference

Panhandle Oil and Gas (NYSE: PHX) is engaged in the exploration for and production of natural gas and oil. The majority of Panhandle Oil and Gas Inc.'s revenues are derived from the production and sale of oil and natural gas. The company's oil and gas holdings, including its 255,000 net mineral acreage and its working interests and royalty interests in producing wells, are primarily located in Arkansas, Oklahoma and Texas. For more information, visit the company’s website at www.panhandleoilandgas.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire…

TuesdayMar 13, 2018 11:00 am

Cronos Group, Inc. (TSX-V: MJN) (PRMCF) Starts Presentation at 30th Annual ROTH Conference

Cronos Group (TSX-V: MJN) (OTC: PRMCF) is a globally diversified and vertically integrated cannabis company operating across four continents. The company runs two wholly-owned Canadian Licensed Producers regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations: Peace Naturals Project Inc. in Ontario, and Original BC Ltd. in British Columbia. Additionally, Cronos has two international production and distribution platforms, Cronos Israel and Cronos Australia. Through an exclusive distribution agreement, Cronos has access to over 12,000 pharmacies in Germany as the company focuses on building an international brand portfolio and developing disruptive intellectual property. For more information, visit the company’s…

TuesdayMar 13, 2018 10:30 am

SenesTech, Inc. (NASDAQ: SNES) Starts Presentation at 30th Annual ROTH Conference

SenesTech (NASDAQ: SNES) is engaged in developing proprietary technologies to manage animal pest populations through fertility control. The company’s focus is on changing the paradigm of pest management by targeting the root problem of reproduction—an approach that can potentially help reduce reliance on lethal methods of rodent control. The company’s ContraPest® is a pioneering technology that targets the reproductive capabilities of both genders within rat populations. ContraPest® is a restricted-use pesticide that employs a proprietary bait delivery method to dispense a highly palatable liquid formulation that fosters sustained consumption in rat communities; it is also designed to pose only low…

TuesdayMar 13, 2018 10:30 am

Control4 Corp. (NASDAQ: CTRL) Starts Presentation at 30th Annual ROTH Conference

Control4 (NASDAQ: CTRL) is a global provider of smart home solutions including automation and networking systems for homes and businesses. The company’s innovative solutions offer personalized control of lighting, music, video, comfort, security, communications, and more into a unified smart home system. By unlocking the potential of connected devices, Control4 makes networks more robust, entertainment systems easier to use, homes more comfortable and energy efficient, and provides families more peace of mind. Leveraging a professional channel that includes over 5,500 custom integrators, retailers, and distributors authorized to sell the full-line of Control4 products, Pakedge branded networking solutions and Triad branded…

TuesdayMar 13, 2018 10:30 am

Biocept, Inc. (NASDAQ: BIOC) Starts Presentation at 30th Annual ROTH Conference

Biocept (NASDAQ: BIOC) is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. By leveraging its proprietary liquid biopsy technology, the company provides physicians with clinically actionable information for treating and monitoring patients diagnosed with cancer. Biocept’s patented Target Selector™ liquid biopsy technology platform identifies and analyzes tumor-associated molecular markers in both circulating tumor cells and in circulating tumor DNA. The platform has demonstrated the ability to identify cancer mutations and alterations to notify physicians about a patient’s disease and therapeutic options. For more information, visit the company’s website at www.biocept.com. About…

TuesdayMar 13, 2018 10:30 am

Agilysys, Inc. (NASDAQ: AGYS) Starts Presentation at 30th Annual ROTH Conference

Agilysys (NASDAQ: AGYS) provides innovative software and services for point-of-sale (POS), property management, reservation and table management, inventory and procurement, workforce management, analytics, document management, and mobile and wireless solutions to the hospitality industry. The company’s advanced products and services enable operators to streamline operations, improve efficiency and understand customer needs to deliver a superior overall guest experience. The company serves major market sectors including corporate foodservice management and restaurants, gaming, hotels, resorts, universities, and healthcare. Agilysys operates across North America, Europe, Asia-Pacific, and India with headquarters located in Alpharetta, GA. For more information, visit the company’s website at www.agilysys.com. About…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: March 2018

Genfit SA (GNFTF) Starts Presentation at 30th Annual ROTH Conference

Vertex Energy, Inc. (NASDAQ: VTNR) Starts Presentation at 30th Annual ROTH Conference

Viking Therapeutics, Inc. (NASDAQ: VKTX) Starts Presentation at 30th Annual ROTH Conference

Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) Starts Presentation at 30th Annual ROTH Conference

Panhandle Oil and Gas, Inc. (NYSE: PHX) Starts Presentation at 30th Annual ROTH Conference

Cronos Group, Inc. (TSX-V: MJN) (PRMCF) Starts Presentation at 30th Annual ROTH Conference

SenesTech, Inc. (NASDAQ: SNES) Starts Presentation at 30th Annual ROTH Conference

Control4 Corp. (NASDAQ: CTRL) Starts Presentation at 30th Annual ROTH Conference

Biocept, Inc. (NASDAQ: BIOC) Starts Presentation at 30th Annual ROTH Conference

Agilysys, Inc. (NASDAQ: AGYS) Starts Presentation at 30th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search